| Literature DB >> 31440624 |
Fumitaka Kugimiya1, Shigeyuki Muraki2, Daisuke Nagakura1, Hidemasa Umekoji1, Hiromi Oda1, Keisuke Takahashi1.
Abstract
INTRODUCTION: Although initial treatments for pyogenic spondylitis include conservative approaches such as rest and antibiotics, some cases are refractory to conservative therapy. The objective of this study was to clarify the predictors for achievement of C-reactive protein (CRP) normalization in pyogenic spondylitis by conservative therapy.Entities:
Keywords: conservative therapy; epidural abscess; paravertebral abscess; pyogenic spondylitis
Year: 2017 PMID: 31440624 PMCID: PMC6698494 DOI: 10.22603/ssrr.1.2017-0009
Source DB: PubMed Journal: Spine Surg Relat Res ISSN: 2432-261X
Characteristics and Complications in Patients with and without NC.
| NC group | non-NC group | P value | ||
|---|---|---|---|---|
| Age (average, yr) | 62.5 | 68.6 | 0.0270 | |
| Men / Women | 34/13 | 17/19 | 0.0198 | |
| Period from onset to admission (days) | 65.2 | 55.3 | 0.1840 | |
| Number of affected vertebrae | 1.90 | 2.60 | 0.0092 | |
|
| ||||
| Diabetes mellitus | 13 (28%) | 12 (33%) | 0.5766 | |
| Hypertension | 11 (23%) | 11 (30%) | 0.4644 | |
| Heart disease | 7 (11%) | 11 (30%) | 0.0862 | |
| Urologic disease | 5 (11%) | 4 (11%) | 0.9453 | |
| Hemodialysis | 0 (0%) | 5 (14%) | 0.0084 | |
| Collagen disease | 2 (4%) | 5 (14%) | 0.1175 | |
| Malignant tumor | 2 (4%) | 3 (8%) | 0.4390 | |
| Liver disease | 2 (4%) | 2 (6%) | 0.7840 | |
| Hyperuricemia | 2 (4%) | 1 (3%) | 0.7208 | |
Non paired Students’t test was used to compare continuous values, and chi square test was used to compare categorical values between NC and non-NC groups.
NC, CRP normalization.
Figure 1.Distribution of the affected vertebrae in patients with and without NC.
NC: normalization of CRP
Laboratory Data in Patients with and without NC.
| NC group | non-NC group | P value | |
|---|---|---|---|
| WBC (/μL) | 10329 | 11378 | 0.218 |
| NEUT (%) | 73.9 | 76.7 | 0.157 |
| LYM (%) | 18.1 | 15.6 | 0.125 |
| Hb (g/dL) | 12.0 | 10.6 | 0.0023 |
| ALB (g/dL) | 3.12 | 2.85 | 0.035 |
| GOT (U/L) | 30.9 | 31.0 | 0.489 |
| GPT (U/L) | 33.9 | 28.7 | 0.289 |
| γ-GPT (U/L) | 65.9 | 50.5 | 0.210 |
| ALP (mU/mL) | 369.3 | 290.1 | 0.030 |
| LDH (U/L) | 207.0 | 229.6 | 0.109 |
| eGFR (ml/min) | 91.2 | 71.8 | 0.029 |
| BUN (mg/dL) | 18.5 | 24.4 | 0.052 |
| Cr (mg/dL) | 0.9 | 1.9 | 0.016 |
| UA (mg/dL) | 5.2 | 5.9 | 0.310 |
| TC (mg/dL) | 163.5 | 183.9 | 0.256 |
| TG (mg/dL) | 152 | 131 | 0.284 |
| LDL (U/L) | 94.1 | 85.2 | 0.292 |
| HDL (U/L) | 45.2 | 42.8 | 0.422 |
| HbA1c (%NGSP) | 7.0 | 6.1 | 0.240 |
| IP (mEq/L) | 5.2 | 3.2 | 0.091 |
WBC, white blood cell; NEUT, neutrophil; LYM, lymphocyte; Hb, hemoglobin; ALB, albumin; GOT, glutamic-oxaloacetic transaminase; GPT, glutamic pyruvic transaminase; γ-GPT, γ-glutamyltransferase; ALP, alkaline phosphatase; LDH, lactate dehydrogenase; eGFR, estimated glomerular filtration rate; BUN, blood urea nitrogen; Cr, creatinine; UA, uric acid; TC, total cholesterol; TG, triglyceride; LDL, low-density lipoprotein; HDL, high-density lipoprotein; HbA1c, hemoglobin A1c; IP, Inorganic phosphorus
Pathogenic Bacteria and Radiological Findings in Patients with and without NC.
| NC group | non-NC group | |||
|---|---|---|---|---|
| Bacteria | ||||
| MSSA | 7 (14.8%) | 6 (16.7%) | ||
| MRSA | 5 (10.6%) | 16 (44.4%) | 0.0005 | |
| Others | 2 (4.3%) | 3 (8.3%) | ||
| Unknown | 33 (70.3%) | 11 (30.6%) | ||
| MRI | ||||
| I, II, III | 34 (72.4%) | 11 (29.7%) | 0.0043 | |
| IV, V | 13 (27.6%) | 25 (70.3%) | ||
Chi square test was used to determine differences between NC and non-NC group. NC, CRP normalization; MSSA, methicillin-sensitive staphylococcus aureus; MRSA, methicillin-resistant staphylococcus aureus
Factors Associated with Achievement of CRP Normalization.
| OR | 95% CI | P value | |
|---|---|---|---|
| Age | 1.03 | 0.998-1.07 | 0.0638 |
| Women (vs. Men) | 1.92 | 0.77-4.90 | 0.1624 |
| Number of affected vertebrae (3 or more vs 2) | 5.61 | 1.60-26.5 | 0.0059 |
| Expansion of abscess (MRI Grade IV, V vs I, II, III) | 4.20 | 1.63-11.5 | 0.0026 |
| ALB | 0.53 | 0.23-1.15 | 0.1116 |
| eGFR | 0.99 | 0.98-1.001 | 0.0751 |
| Hb (1g/dl decrease) | 1.31 | 1.04-1.69 | 0.0206 |
| Resistant pathogenic bacteria | 7.70 | 1.97-42.4 | 0.0023 |
OR was calculated by using multiple logistic regression analysis after adjustment for age and BMI. OR, odds ratio; CI, confidence interval; ALB, albumin; eGFR, estimated glomerular filtration rate; Hb, hemoglobin
Independent Association of Number of Affected Vertebrae, Expansion of Abscess, Serum Hb Level and Resistant Pathogenic Bacteria with Achievement of CRP Normalization.
| OR | 95% CI | P value | |
|---|---|---|---|
| Number of affected vertebrae (3 or more vs 2) | 3.17 | 0.75-17.0 | 0.1183 |
| Expansion of abscess (MRI Grade IV, V vs I, II, III) | 3.40 | 1.17-10.7 | 0.0245 |
| Hb (1g/dl decrease) | 1.34 | 0.74-1.04 | 0.0232 |
| Resistant pathogenic bacteria | 4.34 | 0.96-26.0 | 0.0563 |
OR was calculated by using multiple logistic regression analysis with age, BMI, number of affected vertebrad, expansion of alscess, serum Hb level and resistant pathogenic bacteria. OR, odds ratio; CI, confidence interval; Hb, hemoglobin